Celcuity (CELC) Non-Current Assets (2016 - 2025)
Celcuity (CELC) posted Non-Current Assets of $899000.0 for Q4 2025, up 77.32% on a QoQ basis from $507000.0 in Q3 2025, and up 62.86% year-over-year from $552000.0 in Q4 2024.
Celcuity (CELC) Non-Current Assets (2016 - 2025) Analysis & Trends
Celcuity's Non-Current Assets history runs 10 years deep, the most recent figure standing at $899000.0 for Q4 2025.
- Quarterly Non-Current Assets rose 62.86% year-over-year to $899000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.4 million (changed 0.08% YoY) and the FY2025 annual result came in at $899000.0, up 62.86% from the prior year.
- Non-Current Assets was $899000.0 for Q4 2025 at Celcuity, up from $507000.0 in the prior quarter.
- Across five years, Non-Current Assets topped out at $899000.0 in Q4 2025 and bottomed at $387356.0 in Q2 2022.
- A 5-year average of $601580.8 and a median of $598035.5 in 2022 frame the typical range for Non-Current Assets.
- Annual changes were most pronounced in 2021 — Non-Current Assets sank 32.56% — and 2023, when it surged 83.51%.
- Celcuity's Non-Current Assets stood at $554345.0 in 2021, then retreated by 8.62% to $506560.0 in 2022, then advanced by 24.13% to $628801.0 in 2023, then dropped by 12.21% to $552000.0 in 2024, then soared by 62.86% to $899000.0 in 2025.
- Business Quant data shows CELC's Non-Current Assets at $899000.0 in Q4 2025, $507000.0 in Q3 2025, and $488000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 21.65 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 5.83 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.95 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 3.95 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.75 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.66 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.96 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 285.82 Mn |
| 10 | Celcuity | 4.13 Bn | 4.13 Bn | - | 899,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 899,000.00 |
| Sep 30, 2025 | 507,000.00 |
| Jun 30, 2025 | 488,000.00 |
| Mar 31, 2025 | 530,000.00 |
| Dec 31, 2024 | 552,000.00 |
| Sep 30, 2024 | 598,531.00 |
| Jun 30, 2024 | 613,623.00 |
| Mar 31, 2024 | 657,935.00 |
| Dec 31, 2023 | 628,801.00 |
| Sep 30, 2023 | 672,746.00 |
| Jun 30, 2023 | 710,851.00 |
| Mar 31, 2023 | 775,276.00 |
| Dec 31, 2022 | 506,560.00 |
| Sep 30, 2022 | 597,540.00 |
| Jun 30, 2022 | 387,356.00 |
| Mar 31, 2022 | 486,001.00 |
| Dec 31, 2021 | 554,345.00 |
| Sep 30, 2021 | 655,119.00 |
| Jun 30, 2021 | 557,846.00 |
| Mar 31, 2021 | 653,086.00 |